JANUS HENDERSON GROUP PLC - 30 Sep 2025 SCHEDULE 13G Report for INOVIO PHARAMACEUITICALS, INC. Common Stock (INO)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
INOVIO PHARAMACEUITICALS, INC. Common Stock
Symbol
INO
Shares outstanding
52,681,613 shares
Disclosed Ownership
3,266,260 shares
Ownership
6.2%
Form type
SCHEDULE 13G
Filing time
14 Nov 2025, 10:34:26 UTC
Date of event
30 Sep 2025
Next filing
08 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 6.2% 3,266,260 0 3,266,260 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 5.3% 2,802,530 0 2,802,530 Kristin Mariani Head of North America Compliance, CCO